πŸ‡ΊπŸ‡Έ FDA
Patent

US 6821522

Tumor Therapy

expired A61KA61K2039/505A61K38/00

Quick answer

US patent 6821522 (Tumor Therapy) held by The Regents of the University of California expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P35/00